lncRNA FOXD2-AS1 confers cisplatin resistance of non-small-cell lung cancer via regulation of miR185-5p–SIX1 axis

Background: Chemoresistance is a major obstacle for chemotherapy failure in non-small-cell lung cancer (NSCLC). lncRNAs are a class of pivotal regulators in various cancers, and the lncRNA FOXD2-AS1 is implicated in the progression of NSCLC. However, it is still unclear whether it regulates chemosen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Peng, Cao, Lei, Yao, Yue-Juan, Jing, Rui-Jun, Wang, Wei, Li, Han-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681567/
https://www.ncbi.nlm.nih.gov/pubmed/31534348
http://dx.doi.org/10.2147/OTT.S197454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681567/
https://www.ncbi.nlm.nih.gov/pubmed/31534348
http://dx.doi.org/10.2147/OTT.S197454

Ejemplares similares